- Home
- TFX vs XENE Comparison
TFX vs XENE Comparison
Compare TFX & XENE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | TFX | XENE |
|---|---|---|
| Founded | 1943 | 1996 |
| Country | United States | Canada |
| Employees | N/A | N/A |
| Industry | Medical/Dental Instruments | Biotechnology: Pharmaceutical Preparations |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 5.8B | 5.2B |
| IPO Year | 1994 | 2014 |
Fundamental Metrics
Financial Performance| Metric | TFX | XENE |
|---|---|---|
| Price | $134.98 | $63.36 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 8 | 11 |
| Target Price | ★ $138.75 | $68.55 |
| AVG Volume (30 Days) | 468.9K | ★ 853.9K |
| Earning Date | 05-07-2026 | 05-08-2026 |
| Dividend Yield | ★ 1.02% | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 2.08 | N/A |
| Revenue | ★ $1,992,713,000.00 | $311,000.00 |
| Revenue This Year | $15.97 | N/A |
| Revenue Next Year | $5.15 | $2,496.48 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $100.18 | $32.78 |
| 52 Week High | $145.00 | $72.66 |
Technical Indicators
Market Signals| Indicator | TFX | XENE |
|---|---|---|
| Relative Strength Index (RSI) | 58.51 | 53.96 |
| Support Level | $121.29 | $52.40 |
| Resistance Level | N/A | $72.66 |
| Average True Range (ATR) | 4.65 | 2.01 |
| MACD | 0.44 | -0.59 |
| Stochastic Oscillator | 59.18 | 44.37 |
Price Performance
Historical ComparisonAbout TFX Teleflex Incorporated
Teleflex Inc is a provider of medical technology products focused on enhancing clinical benefits, improving patient and provider safety and reducing total procedural costs. It designs, develops, manufactures and supply medical devices used by hospitals and healthcare providers supporting high-acuity emergent procedures. The company has three reportable segments: Americas, EMEA (Europe, the Middle East and Africa) and Asia (Asia Pacific). It derives maximum revenue from Americas. Its products includes: Anaesthesia, Emergency Medicine, Interventional Cardiology/Radiology, Interventional Urology - UroLift System, Surgery, Urology, and Vascular Access.
About XENE Xenon Pharmaceuticals Inc.
Xenon Pharmaceuticals Inc is a neuroscience-focused biopharmaceutical company committed to improving the lives of people living with neurological and psychiatric disorders. It is advancing a novel product pipeline to address areas of high unmet medical need, including epilepsy and depression. The product candidates of the group include XEN1101, NBI-921352, and XEN496 for Epilepsy and Nav1.7 oral inhibitors for Pain.